323 related articles for article (PubMed ID: 15188503)
1. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.
Cheng G; An F; Zou MJ; Sun J; Hao XH; He YX
World J Gastroenterol; 2004 Jun; 10(12):1769-74. PubMed ID: 15188503
[TBL] [Abstract][Full Text] [Related]
2. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
3. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
4. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
Zambito Y; Di Colo G
J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery.
Freire C; Podczeck F; Ferreira D; Veiga F; Sousa J; Pena A
J Pharm Pharmacol; 2010 Jan; 62(1):55-61. PubMed ID: 20722999
[TBL] [Abstract][Full Text] [Related]
8. Selective drug delivery to the colon using pectin-coated pellets.
He W; Qing D; Cao DY; Fan LF; Xiang B
PDA J Pharm Sci Technol; 2008; 62(4):264-72. PubMed ID: 19174955
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
Xu M; Sun M; Qiao H; Ping Q; Elamin ES
Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.
Fude C; Lei Y; Jie J; Hongze P; Wenhui L; Dongmei C
Drug Dev Ind Pharm; 2007 Sep; 33(9):999-1007. PubMed ID: 17891587
[TBL] [Abstract][Full Text] [Related]
11. [Studies on diclofenac sodium pulsatile release pellets].
Guo T; Zheng CL; Song HT; Sui Y; Dang DS; Sun XH
Yao Xue Xue Bao; 2003 Sep; 38(9):707-10. PubMed ID: 14730924
[TBL] [Abstract][Full Text] [Related]
12. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 5-ASA layered or matrix pellets coated with a combination of ethylcellulose and eudragits L and s in the treatment of ulcerative colitis in rats.
Sardou HS; Sadeghi F; Garekani HA; Akhgari A; Hossein Jafarian A; Abbaspour M; Nokhodchi A
Int J Pharm; 2023 Jun; 640():122981. PubMed ID: 37120124
[TBL] [Abstract][Full Text] [Related]
14. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
15. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
16. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
[TBL] [Abstract][Full Text] [Related]
17. [Ulcerative colitis--colon delivery of 5-aminosalicylic acid].
Muraoka M; Kimura G; Zhaopeng H; Takada K
Nihon Rinsho; 1998 Mar; 56(3):788-94. PubMed ID: 9549374
[TBL] [Abstract][Full Text] [Related]
18. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
[TBL] [Abstract][Full Text] [Related]
19. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
[TBL] [Abstract][Full Text] [Related]
20. Composite film-coated tablets intended for colon-specific delivery of 5-aminosalicylic acid: using deesterified pectin.
Sriamornsak P; Nunthanid J; Wanchana S; Luangtana-Anan M
Pharm Dev Technol; 2003 Aug; 8(3):311-8. PubMed ID: 12901696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]